You have 9 free searches left this month | for more free features.

local advanced colorectal cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Cancer, Colorectal Cancer Trial (MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 mAb neoadjuvant

Not yet recruiting
  • Multiple Cancer
  • Colorectal Cancer
  • MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 monoclonal antibody neoadjuvant therapy
  • All-MSI-H (dMMR) sMPCC: single-drug PD-1 monoclonal antibody neoadjuvant therapy
  • (no location specified)
Aug 20, 2023

Colorectal Cancer, Adjuvant Chemo Trial in Guangzhou (wait and watch, adjuvant chemo)

Recruiting
  • Colorectal Cancer
  • Adjuvant Chemotherapy
  • wait and watch
  • adjuvant chemotherapy
  • Guangzhou, Guangdong, China
    Sixth Affiliated Hospital of Sun Yat-sen University
Jan 25, 2022

Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in Guangzhou (Neoadjuvant

Recruiting
  • Colorectal Cancer
  • +3 more
  • Neoadjuvant therapy with PD-L1 inhibitor
  • Guangzhou, Guangdong, China
    the Third Affiliated Hospital of Sun Yat-Sen University
May 10, 2022

Advanced Colorectal Cancer, Circulating Tumor DNA Trial in Shanghai (Local treatment)

Recruiting
  • Advanced Colorectal Cancer
  • Circulating Tumor DNA
  • Local treatment
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 8, 2022

Rectal Cancer Trial in Shanghai (FOLFOXIRI, CapeOX)

Recruiting
  • Rectal Cancer
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery Fudan University Shanghai Caner
Feb 16, 2022

Colorectal Cancer, Immunotherapy Trial in Guangzhou (mFOLFOX6+Bevacizumab+PD-1 mAb treatment combinations)

Recruiting
  • Colorectal Cancer
  • Immunotherapy
  • mFOLFOX6+Bevacizumab+PD-1 monoclonal antibody treatment combinations
  • Guangzhou, Guangdong, China
    Sun Yatsen University
May 19, 2021

Colorectal Cancer Metastatic Trial in Philadelphia (Local consolidative therapy)

Withdrawn
  • Colorectal Cancer Metastatic
  • Local consolidative therapy
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Dec 7, 2022

Locally Advanced Colorectal Cancer Trial (Capecitabine, Oxaliplatin, Bevacizumab)

Not yet recruiting
  • Locally Advanced Colorectal Cancer
  • (no location specified)
Oct 18, 2022

Advanced Colorectal Cancer Trial in Hangzhou (Cetuximab Dabrafenib Tislelizumab)

Not yet recruiting
  • Advanced Colorectal Cancer
  • Cetuximab Dabrafenib Tislelizumab
  • Hangzhou, Zhejing, China
    Zhejiang Cancer Institute & Hospital
Jul 19, 2023

Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H

Recruiting
  • Colorectal Cancer
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Oct 18, 2023

    Colon Cancer, Neoadjuvant Therapy, Immunotherapy Trial in Guangzhou (Envafolimab, CAPEOX)

    Recruiting
    • Colon Cancer
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Aug 26, 2023

    Advanced Colorectal Cancer Trial in Hangzhou (Fruquintinib Combined With Chemotherapy)

    Not yet recruiting
    • Advanced Colorectal Cancer
    • Fruquintinib Combined With Chemotherapy
    • Hangzhou, Zhejing, China
      Zhejiang Cancer Institute & Hospital
    Jun 29, 2023

    Advanced Solid Tumors Trial in Worldwide (BMS-986466, Adagrasib, Cetuximab)

    Not yet recruiting
    • Advanced Solid Tumors
    • Birmingham, Alabama
    • +24 more
    Aug 29, 2023

    Colorectal Cancer, Oligometastatic Disease Trial in Australia (Local Ablative Therapy, Standard first-line systemic treatment)

    Recruiting
    • Colorectal Cancer
    • Oligometastatic Disease
    • Local Ablative Therapy
    • Standard first-line systemic treatment
    • Albury, New South Wales, Australia
    • +8 more
    May 15, 2023

    HER2, Colorectal Cancer Trial (Disitamab Vedotin Combined With Fruquintinib)

    Not yet recruiting
    • HER2
    • Colorectal Cancer
    • Disitamab Vedotin Combined With Fruquintinib
    • (no location specified)
    Dec 21, 2022

    Colorectal Cancer, Liver Metastases, MSS Trial (Sinti+Rego+Cele)

    Not yet recruiting
    • Colorectal Cancer
    • +2 more
    • (no location specified)
    Jul 3, 2023

    Advanced Colorectal Carcinoma Trial in Beijing (palliative care group first-line scheme+compound kushen injection, palliative

    Recruiting
    • Advanced Colorectal Carcinoma
    • palliative care group first-line scheme+compound kushen injection
    • palliative care group first-line scheme
    • Beijing, China
      Guang 'anmen Hospital, China Academy of Chinese Medical Sciences
    Jun 7, 2023

    Colorectal Cancer Trial in Tai'an (Tas-102(Suyuan) combined with bevacizumab)

    Not yet recruiting
    • Colorectal Cancer
    • Tas-102(Suyuan) combined with bevacizumab
    • Tai'an, Shandong, China
      The Second Affiliated Hospital of Shandong First Medical Univers
    Oct 14, 2023

    Colorectal Cancer Trial in Durham (VR Blue)

    Completed
    • Colorectal Cancer
    • VR Blue
    • Durham, North Carolina
      Duke Cancer Institute
    Jul 27, 2022

    Colorectal Cancer Trial in Shanghai (FOLFIRI+Bevacizumab)

    Recruiting
    • Colorectal Cancer
    • Shanghai, Pudong, China
      Affiliated Cancer Hospital of Fudan University
    Jul 24, 2023

    Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and

    Not yet recruiting
    • Colorectal Neoplasms
    • Beijing, Xicheng Dis, China
      Beijing Friendship Hospital, Capital medical University
    Sep 5, 2023

    Rectal Cancer Trial in Chongqing (CIETAI-R)

    Recruiting
    • Rectal Cancer
    • CIETAI-R
    • Chongqing, Chongqing, China
      Daping Hospital, Third Military Medical University
    Jul 21, 2023

    Test for Colorectal Cancer and Advanced Adenoma

    Not yet recruiting
    • Colorectal Cancer
    • +3 more
    • Mainz Biomed Colorectal Cancer Screening Test
    • (no location specified)
    Dec 6, 2022

    Colorectal Cancer Trial in Taipei (Robotic surgery)

    Recruiting
    • Colorectal Cancer
    • Robotic surgery
    • Taipei, Taiwan
      Jin-Tung LIANG
    Jul 27, 2023